Heartland Assays

Cancer

2019

Ng K, Nimeiri HS, McCleary NJ, et al. 2019

Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial. JAMA. 2019 Apr 9;321(14):1370-1379
view abstract

2016

Verone-Boyle AR, Shoemaker S, Attwood K, et al. 2016

Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo. Oncotarget. 2016 Jan 5;7(1):995-1013
view abstract

2011

Weinstein SJ, Yu K, Horst RL, et al. 2011

Serum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case-control study., PLoS One 6: e20796
view abstract

Arem H, Weinstein SJ, Horst RL, et al. 2011

Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men., Cancer Epidemiol Biomarkers Prev 20: 1178-84
view abstract

2010

Mondul AM, Weinstein SJ, Männistö S, et al. 2010

Serum vitamin D and risk of bladder cancer., Cancer Res 70: 9218-23
view abstract

Abnet CC, Chen Y, Chow WH, et al. 2010

Circulating 25-hydroxyvitamin D and risk of esophageal and gastric cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers., Am J Epidemiol 172: 94-106
view abstract

McCullough ML, Weinstein SJ, Freedman DM, et al. 2010

Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers., Am J Epidemiol 172: 21-35
view abstract

Zeleniuch-Jacquotte A, Gallicchio L, Hartmuller V, et al. 2010

Circulating 25-hydroxyvitamin D and risk of endometrial cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers., Am J Epidemiol 172: 36-46
view abstract

Gallicchio L, Helzlsouer KJ, Chow WH, et al. 2010

Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers., Am J Epidemiol 172: 10-20
view abstract

Gallicchio L, Moore LE, Stevens VL, et al. 2010

Circulating 25-hydroxyvitamin D and risk of kidney cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers., Am J Epidemiol 172: 47-57
view abstract

Zheng W, Danforth KN, Tworoger SS, et al. 2010

Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers., Am J Epidemiol 172: 70-80
view abstract

Purdue MP, Freedman DM, Gapstur SM, et al. 2010

Circulating 25-hydroxyvitamin D and risk of non-hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers., Am J Epidemiol 172: 58-69
view abstract

Woolcott CG, Wilkens LR, Nomura AM, et al. 2010

Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study., Cancer Epidemiol Biomarkers Prev 19: 130-4
view abstract

Asgari MM, Tang J, Warton ME, et al. 2010

Association of prediagnostic serum vitamin D levels with the development of basal cell carcinoma, J Invest Dermatol 130: 1438-43
view abstract

2009

Ng K, Wolpin BM, Meyerhardt JA, et al. 2009

Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer., Br J Cancer 101: 916-23
view abstract

Garland CF, Grant WB, Boucher BJ, et al. 2009

Open letter to IARC Director Christopher P. Wild-Re: IARC Working Group Report 5: Vitamin D and Cancer, Dermatoendocrinol 1: 119-20
view abstract

Stolzenberg-Solomon RZ, Hayes RB, Horst RL, et al. 2009

Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial., Cancer Res 69: 1439-47
view abstract

Lim U, Freedman DM, Hollis BW, et al. 2009

A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers., Int J Cancer 124: 979-86
view abstract

2008

Heist RS, Zhou W, Wang Z, et al. 2008

Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer., J Clin Onco 26: 5596-602
view abstract

Ng K, Meyerhardt JA, Wu K, et al. 2008

Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer., J Clin Oncol 26: 2984-91
view abstract

Egan KM, Signorello LB, Munro HM, et al. 2008

Vitamin D insufficiency among African-Americans in the southeastern United States: implications for cancer disparities (United States)., Cancer Causes Control 19: 527-35
view abstract

Freedman DM, Chang SC, Falk RT, et al. 2008

Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial., Cancer Epidemiol Biomarkers Prev 17: 889-94
view abstract

2007

Wu K, Feskanich D, Fuchs CS, et al. 2007

A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer., J Natl Cancer Inst 99: 1120-9
view abstract

Tworoger SS, Lee IM, Buring JE, et al. 2007

Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer., Cancer Epidemiol Biomarkers Prev 16: 783-8
view abstract

Zhou W, Heist RS, Liu G, Asomaning K, et al. 2007

Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients, J Clin Oncol 25: 479-85
view abstract

2006

Giovannucci E, Liu Y, Rimm EB, et al. 2006

Prospective study of predictors of vitamin D status and cancer incidence and mortality in men, J Natl Cancer Inst 98: 451-9
view abstract

2004

Feskanich D, Ma J, Fuchs CS, et al. 2004

Plasma vitamin D metabolites and risk of colorectal cancer in women., Cancer Epidemiol Biomarkers Prev 13: 1502-8
view abstract

Peters U, Hayes RB, Chatterjee N, et al. 2004

Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk., Cancer Epidemiol Biomarkers Prev 13: 546-52
view abstract

2001

Sunita Rao D, Balkundi D, Uskokovic MR, et al. 2001

Double bond in the side chain of 1alpha,25-dihydroxy-22-ene-vitamin D(3) is reduced during its metabolism: studies in chronic myeloid leukemia (RWLeu-4) cells and rat kidney., J Steroid Biochem Mol Biol 78: 167-76
view abstract

1997

Tangrea J, Helzlsouer K, Pietinen P, et al. 1997

Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men., Cancer Causes Control 8: 615-25
view abstract

1995

Hustmyer FG, Beitz DC, Goff JP, et al. 1995

In vivo parathyroid hormone stimulates in vitro bone resorption by bovine monocytes., J Dairy Sci. 78: 2700-8
view abstract

Johnson JA, Beckman MJ, Pansini-Porta A, et al. 1995

Age and gender effects on 1,25-dihydroxyvitamin D3-regulated gene expression., Exp Gerontol 30: 631-43
view abstract

1986

Bar-Shavit Z, Horst RL, Chappel JC, et al. 1986

25-Hydroxyvitamin D3 metabolism in a human leukemia cell line., Calcif Tissue Int 39: 328-33
view abstract

1980

Stewart AF, Horst R, Deftos LJ, et al. 1980

Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups., N Engl J Med 303: 1377-83
view abstract


© 2024 Heartland Assays - All rights reserved.